Suchergebnisse - "Duan, Kai"

PubPharm (16)

1

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China

enthalten in: Emerging microbes & infections | 2024

von Liu, Y. | Zhang, J. | Liu, W. | +20

2

Rational design of a 'two-in-one' immunogen DAM drives potent immune response against mpox virus

enthalten in: Nature immunology | 2024

von Wang, H. | Yin, P. | Zheng, T. | +21

ErratumIn: Nat Immunol. 2024 Jan 15;:. - PMID 38225438

3

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old : Randomized, blinded, parallel controlled phase III clinical study

enthalten in: Human vaccines & immunotherapeutics | 2023

von Huang, X. | Liang, J. | Huang, L. | +18

4

Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants : A randomized, double-blind, placebo-controlled phase 2 clinical trial

enthalten in: Human vaccines & immunotherapeutics | 2023

von Wu, Z. | Jin, F. | Li, Q. | +14

5

Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection : A preclinical study

enthalten in: Antiviral research | 2023

von Zhang, J. | Nian, X. | Liu, B. | +18

6

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above : a phase III randomized controlled clinical study

enthalten in: Human vaccines & immunotherapeutics | 2022

von Fan, R. | Huang, X. | Nian, X. | +13

7

Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial

enthalten in: Human vaccines & immunotherapeutics | 2022

von Chen, J. | Jin, P. | Chen, X. | +19

8

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years : a phase III randomized clinical noninferiority trial

enthalten in: Human vaccines & immunotherapeutics | 2022

von Huang, X. | Fan, T. | Li, L. | +16

9

Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants

enthalten in: Virologica Sinica | 2022

von Lu, J. | Yin, Q. | Pei, R. | +18

10

Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan

enthalten in: Nature communications | 2021

von Li, C. | Yu, D. | Wu, X. | +33

ErratumIn: Nat Commun. 2021 Aug 5;12(1):4846. - PMID 34354086